Deborah E. Shalev
Impact in
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
- Microbiology top 1%
- Antimicrobial Peptides and Activities
Papers in
-
- Chemical Synthesis and Analysis 15
- Protein Structure and Dynamics 9
- Biochemical and Structural Characterization 6
- RNA and protein synthesis mechanisms 6
-
- Carbohydrate Chemistry and Synthesis 5
- Co-authors
- Ehud Gazit (9 shared papers)I. M. Kustanovich (4 shared papers)Saleh Abu‐Lafi (1 shared paper)Raphael Mechoulam (1 shared paper)Zvi Vogel (1 shared paper)Aviva Breuer (1 shared paper)Ester Fride (1 shared paper)Amram Mor (3 shared papers)
- Journals
- Journal of Biological Chemistry (6 papers)PLoS ONE (4 papers)Biopolymers (4 papers)Bioorganic & Medicinal Chemistry (4 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Deborah E. Shalev
73 papers receiving 2.6k citations
Deborah E. Shalev's Hit Papers
Peers
Comparison fields: 5 of 118
- Pharmacology 764
- Microbiology 285
- Toxicology 83
- Biomaterials 332
- Virology 104
Countries citing papers authored by Deborah E. Shalev
This map shows the geographic impact of Deborah E. Shalev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah E. Shalev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah E. Shalev more than expected).
Fields of papers citing papers by Deborah E. Shalev
This network shows the impact of papers produced by Deborah E. Shalev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah E. Shalev. The network helps show where Deborah E. Shalev may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah E. Shalev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor Hit paper breakdown → | 2001 | 588 |
| 2 | 2006 | 197 | |
| 3 | 2002 | 140 | |
| 4 | 2010 | 127 | |
| 5 | 2008 | 125 | |
| 6 | 2010 | 98 | |
| 7 | 2020 | 94 | |
| 8 | 2009 | 78 | |
| 9 | 2008 | 70 | |
| 10 | 2007 | 69 | |
| 11 | 2002 | 55 | |
| 12 | 2009 | 53 | |
| 13 | 2008 | 44 | |
| 14 | 2008 | 44 | |
| 15 | 2007 | 43 | |
| 16 | 2010 | 42 | |
| 17 | 1996 | 41 | |
| 18 | 2008 | 39 | |
| 19 | 2012 | 33 | |
| 20 | 2019 | 32 |
About Deborah E. Shalev
Deborah E. Shalev is a scholar working on Molecular Biology, Organic Chemistry, Cellular and Molecular Neuroscience, Physiology and Biomaterials, having authored 75 papers that have together received 2.7k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (15 papers), Protein Structure and Dynamics (9 papers), Alzheimer's disease research and treatments (8 papers), HIV Research and Treatment (7 papers), Supramolecular Self-Assembly in Materials (7 papers), Biochemical and Structural Characterization (6 papers), RNA and protein synthesis mechanisms (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). The work is most often cited by research in Pharmacology (764 citations), Microbiology (285 citations), Toxicology (83 citations), Biomaterials (332 citations) and Virology (104 citations). Deborah E. Shalev has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Ehud Gazit, I. M. Kustanovich, Saleh Abu‐Lafi, Raphael Mechoulam, Zvi Vogel, Aviva Breuer, Ester Fride, Amram Mor, Anat Frydman‐Marom and Assaf Friedler. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE, Biopolymers, Bioorganic & Medicinal Chemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.